MDM2 SNP309 modifies the prognostic significance of the p53 mutational status in patients with ovarian cancer

By                            

Oncology Reports, Vol. 27, Iss. 3, 2012-01 ,pp. : 673-677

Spandidos Publications

Access to resources Recommend Favorite

P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

By Levidou Georgia   El-Habr Elias   Saetta Angelica   Bamias Christine   Katsougiannis Klea   Patsouris Efstratios   Korkolopoulou Penelope  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 363-371

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: P53 immunoexpression as a prognostic marker for human astrocytomas: a meta-analysis and review of the literature

By Levidou Georgia   El-Habr Elias   Saetta Angelica   Bamias Christine   Katsouyanni Klea   Patsouris Efstratios   Korkolopoulou Penelope  

Journal of Neuro-Oncology, Vol. 100, Iss. 3, 2010-12 ,pp. : 373-373

Springer Publishing Company

Access to resources Recommend Favorite

Expression of p53 and mdm2 mRNA and protein in colorectal carcinomas

By Broll R.   Stark A.   Windhovel U.   Best R.   Strik M.W.   Schimmelpenning H.   Schwandner O.   Kujath P.   Bruch H.-P.   Duchrow M.  

European Journal of Cancer, Vol. 35, Iss. 7, 1999-07 ,pp. : 1083-1088

Elsevier

Access to resources Recommend Favorite

The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 1, 2014-01 ,pp. : 46-51

Bentham Science Publishers

Access to resources Recommend Favorite